XNASKEQU
Market cap154mUSD
Dec 23, Last price
53.70USD
1D
-0.32%
1Q
59.73%
Jan 2017
119.63%
Name
Kewaunee Scientific Corp
Chart & Performance
Profile
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. It operates through two segments, Domestic and International. The company's products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. Its laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture; and laminate caseworks that are used in educational, healthcare, and industrial applications. The company sells its products primarily through dealers, its subidiaries, and a national distributor. Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑04 | 2023‑04 | 2022‑04 | 2021‑04 | 2020‑04 | 2019‑04 | 2018‑04 | 2017‑04 | 2016‑04 | 2015‑04 | |
Income | ||||||||||
Revenues | 203,755 -7.17% | 219,494 29.98% | 168,872 14.51% | |||||||
Cost of revenue | 190,571 | 214,850 | 172,442 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 13,184 | 4,644 | (3,570) | |||||||
NOPBT Margin | 6.47% | 2.12% | ||||||||
Operating Taxes | (5,938) | 3,139 | 3,518 | |||||||
Tax Rate | 67.59% | |||||||||
NOPAT | 19,122 | 1,505 | (7,088) | |||||||
Net income | 18,753 1,279.91% | 1,359 -122.64% | (6,003) 66.43% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | (1,998) | |||||||||
BB yield | 1.90% | |||||||||
Debt | ||||||||||
Debt current | 5,333 | 5,639 | 3,033 | |||||||
Long-term debt | 13,572 | 72,884 | 14,259 | |||||||
Deferred revenue | (943) | |||||||||
Other long-term liabilities | 30,890 | (24,131) | 33,465 | |||||||
Net debt | (4,362) | 69,340 | 11,640 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 19,564 | (3,790) | (7,885) | |||||||
CAPEX | (4,373) | (4,148) | (1,908) | |||||||
Cash from investing activities | (4,373) | (4,148) | (1,908) | |||||||
Cash from financing activities | (3,014) | 14,931 | 11,031 | |||||||
FCF | 26,916 | 1,071 | (23,651) | |||||||
Balance | ||||||||||
Cash | 23,267 | 8,078 | 4,433 | |||||||
Long term investments | 1,105 | 1,219 | ||||||||
Excess cash | 13,079 | |||||||||
Stockholders' equity | 52,854 | 33,479 | 31,750 | |||||||
Invested Capital | 85,022 | 83,541 | 79,085 | |||||||
ROIC | 22.69% | 1.85% | ||||||||
ROCE | 13.27% | 5.50% | ||||||||
EV | ||||||||||
Common stock shares outstanding | 2,938 | 2,902 | 2,786 | |||||||
Price | 35.70 119.69% | 16.25 13.96% | 14.26 18.83% | |||||||
Market cap | 104,887 122.42% | 47,158 18.70% | 39,728 19.95% | |||||||
EV | 101,974 | 117,574 | 51,854 | |||||||
EBITDA | 16,309 | 7,511 | (801) | |||||||
EV/EBITDA | 6.25 | 15.65 | ||||||||
Interest | 1,799 | 1,734 | 632 | |||||||
Interest/NOPBT | 13.65% | 37.34% |